IS8239A - Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur - Google Patents

Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur

Info

Publication number
IS8239A
IS8239A IS8239A IS8239A IS8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A IS 8239 A IS8239 A IS 8239A
Authority
IS
Iceland
Prior art keywords
bicyclic
neuroprotective drugs
heptane derivative
produce neuroprotective
produce
Prior art date
Application number
IS8239A
Other languages
English (en)
Inventor
βn Gacs βlyi Istv
βbor Gigler G
βszlo G βbor H βrsing L
Lévay György
Moricz Krisztina
βria Simo Annam
βbor Szén βsi G
Original Assignee
Egis Gyogyszergy βr Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergy βr Rt. filed Critical Egis Gyogyszergy βr Rt.
Publication of IS8239A publication Critical patent/IS8239A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IS8239A 2003-06-23 2006-01-18 Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur IS8239A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301906A HUP0301906A3 (en) 2003-06-23 2003-06-23 Use of bicyclo[2.2.1]heptane derivatives for producing of pharmaceutical compositions having neuroprotectiv activity
PCT/HU2004/000062 WO2004112769A1 (en) 2003-06-23 2004-06-22 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IS8239A true IS8239A (is) 2006-01-18

Family

ID=90001689

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8239A IS8239A (is) 2003-06-23 2006-01-18 Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur

Country Status (23)

Country Link
US (1) US20060258750A1 (is)
EP (1) EP1660063A1 (is)
JP (1) JP2007516165A (is)
KR (1) KR20060023997A (is)
CN (1) CN1812778A (is)
AU (1) AU2004248982A1 (is)
BG (1) BG109414A (is)
BR (1) BRPI0411772A (is)
CA (1) CA2529254A1 (is)
CZ (1) CZ200631A3 (is)
EA (1) EA010868B1 (is)
HR (1) HRP20060023A2 (is)
HU (1) HUP0301906A3 (is)
IL (1) IL172408A0 (is)
IS (1) IS8239A (is)
MX (1) MXPA05014127A (is)
NO (1) NO20060277L (is)
PL (1) PL378630A1 (is)
RS (1) RS20050954A (is)
SK (1) SK50082006A3 (is)
UA (1) UA81052C2 (is)
WO (1) WO2004112769A1 (is)
ZA (1) ZA200510138B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
WO2007132841A1 (ja) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited 縮合複素環化合物およびその用途
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF
CZ2008602A3 (cs) * 2008-10-09 2009-11-25 Ústav chemických procesu Akademie ved Ceské republiky Zpusob a zarízení pro izolaci kyseliny tereftalové
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
US11478467B2 (en) 2017-05-04 2022-10-25 Sreenivasarao Vepachedu Targeted drug rescue with novel compositions, combinations, and methods thereof
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC FOR EXERCISE INCONTINENCE AND STAIR INCONTINENCE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335371B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Method for inducing cognition enhancement
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use

Also Published As

Publication number Publication date
EP1660063A1 (en) 2006-05-31
SK50082006A3 (sk) 2006-05-04
IL172408A0 (en) 2006-04-10
HUP0301906A3 (en) 2006-03-28
PL378630A1 (pl) 2006-05-15
ZA200510138B (en) 2007-03-28
UA81052C2 (en) 2007-11-26
HRP20060023A2 (en) 2006-05-31
KR20060023997A (ko) 2006-03-15
CN1812778A (zh) 2006-08-02
HUP0301906D0 (en) 2003-08-28
WO2004112769A1 (en) 2004-12-29
AU2004248982A1 (en) 2004-12-29
CA2529254A1 (en) 2004-12-29
EA010868B1 (ru) 2008-12-30
MXPA05014127A (es) 2006-02-24
NO20060277L (no) 2006-01-19
BRPI0411772A (pt) 2006-08-08
RS20050954A (en) 2007-08-03
CZ200631A3 (cs) 2006-05-17
HUP0301906A2 (en) 2006-02-28
EA200600022A1 (ru) 2006-08-25
BG109414A (bg) 2006-11-30
JP2007516165A (ja) 2007-06-21
US20060258750A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
IL163667A0 (en) Novel sustained release pharmaceutical compounds to preventabuse of controlled substances
CY2016031I2 (el) Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
MA26903A1 (fr) Production continue de granules pharmaceutiques
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
IL172733A0 (en) Diphenylpyridine derivatives, preparation and therapeutic application thereof
NO20050970L (no) Fremstilling av et fermenteringsprodukt
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
IS8239A (is) Notkun tvíhring[2.2.1] heptanafleiða til að framleiða taugaverndandi lyfjablöndur
EP1589917A4 (en) METHOD FOR THE ADMINISTRATION OF A DERMATOLOGICAL AGENT TO A PROBAND
NO20052914D0 (no) Terapeutiske forbindelser
AU2003261935A1 (en) Furan or thiophene derivative and medicinal use thereof
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
EP1664627A4 (en) FUNCTIONAL APPLICATION OF PHOTOCHROME CONNECTING MATERIALS TO PRODUCTS
EP1551426A4 (en) PROCESS FOR THE ADMINISTRATION OF FGF18
HK1089671A1 (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
IS7564A (is) Lyfjablanda með breytta losun
AU2003225432A1 (en) Delivery of a substance to a pre-determined site
AU2003296878A1 (en) Methods to administer epothilone d
FR2873294B1 (fr) Association de medicaments
NO20052177D0 (no) Anvendelse av galantamin og dets derivater for fremstilling av legemidler
IL175674A0 (en) Method to improve the efficacy of therapeutic radiolabeled drugs
AU2003901647A0 (en) Novel Condensed Furan Compounds and Pharmaceutical Use Thereof
GB0327742D0 (en) Novel uses of known drugs
AU2003233286A1 (en) Pth derivatives resistant to skin proteases